ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CLL Cello Health Plc

161.00
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 161.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cello Health Share Discussion Threads

Showing 626 to 649 of 1100 messages
Chat Pages: Latest  32  31  30  29  28  27  26  25  24  23  22  21  Older
DateSubjectAuthorDiscuss
08/5/2013
14:08
I brought into CLL again on release of the full year results in March, the statement seemed to indicate that a strong recovery was underway, after the restructering undertaken in the previous year. My view was strengthened when both the FD and CEO purchased more shares after the results.

So as long as the AGM statements confirms that the strong performance from Q4 has continued into this financial year, I would be happy to increase my holding again.

By lack of posts here and comments elsewhere, it would seem that the improved trading hasn't been picked up yet.

ic2...

interceptor2
08/5/2013
13:18
Glad you guys brought this to my attention, was wondering when agm was this month.....dyor but looks like 14 may from web-site.....good to have been able to buy the dips.....any other thoughts?
qs9
07/5/2013
22:25
I also have held CRE before, but took them off my watchlist in July 2012 after they disappointed me once too often. Can't say that I have seen any news since that has made me look at them in more detail.

I seem to remember some option awards to directors, that were based on UK GDP figures, wasn't impressed by that at the time.

ic2...

interceptor2
07/5/2013
18:21
Lets just say i much prefer CLL over CRE. I have held CRE in the past but it never did perform how i had hoped.
cfro
07/5/2013
17:15
ic2, cfro - How do you think this stacks up against Creston? The latter screens well but I have not bought any because of my long held position here.
hpcg
07/5/2013
15:13
Thinking the exact same things as you ic2, as particulary after the CEO bought i should have also bought more then but i was waylayed at the time buying/selling other stuff and didnt seem to get round to it.

I have rectified the situation today tho.

cfro
07/5/2013
13:40
When the FD brought at 47p and then the CEO at 50.78p, I was a bit slow to react. I was only holding my initial investment and should have brought more, so happy to have another chance.

The situation now reminds me of May 2010, when I first brought in here at 34p, directors soon brought stock just below at 32p, and as trading continued strongly through 2010, the share price almost doubled within a year, before falling back again during 2011.

ic2...

interceptor2
07/5/2013
11:53
Looks a good price to buy in at ic2 imo. Very quiet bb and quiet share price too. Its funny that it had crossed my mind to think about another top-up myself.
cfro
07/5/2013
11:03
CLL historically issues an AGM statement between 15th to 17th May, so we should see one next week between Wednesday to Friday or the following Monday?

I did purchase some more this morning and will look for confirmation within the AGM statement, that the strong turnaround reported at the full year reults in March, is continuing.

Didn't think I would have a chance to buy at a level close to the FD or below the CEOs recent purchase.

ic2...

interceptor2
19/4/2013
11:23
Interested to see who bought 2% of the company yesterday.
coopstock
19/4/2013
08:15
Product launch from FACE one of CLL's divisions.

"Having doubled the size in the past 12 months with offices in New York, Singapore and Hong Kong, Pulsar TRAC is the first in a series of planned product releases from face which marks an evolution of the business from a research agency to a technology driven consultancy".

cfro
09/4/2013
08:27
With both the FD and now the CEO buying shares, it sounds like the strong momentum reported last month, is continuing into the new financial year.

ic2...

interceptor2
09/4/2013
07:59
CEO share purchase.
cfro
22/3/2013
10:49
Up again today. Forward pe is still around seven.
cfro
20/3/2013
15:56
On a breakout now....
cfro
20/3/2013
15:06
Must be using an internet broker - a straight buy order tends not go inside the spread. However given the other trades today one would think that they left 5% on the table. It wouldn't surprise me if we find out it was another officer.
hpcg
20/3/2013
14:46
sp increasing further now with more buyers arriving, someone just paid 50p for 10k. Either CLL shares are about to rise further, or he needs a new broker.

ic2...

interceptor2
20/3/2013
08:34
Very good news

You may remember cfro because I think you were holding at the time, the last time M Bently brought share was June 2010 at 32p, the share price doubled within 7 months that time :o)

That time the Chairman and CEO brought on the same day, but the CEO has been buying recently.

ic2...

interceptor2
20/3/2013
07:56
Thanks for the article IC2.

FD bought a few @47p. :-)

cfro
15/3/2013
16:38
Thats an unexpected move, nice....:-)
cfro
14/3/2013
13:39
With the restructuring completed into two focused operating sectors now, Cello Health and Cello Consumer, I had the feeling reading yesterdays results, that they have turned the corner now and were sounding more confident about the future. Cello Health continued it's strong performance from Q4 into the new financial year, and Cello Consumer has made a good recovery.

International business has now increased to 46.1% of revenue, with a good increase seen in the USA and Asia Pacific, in 2009, International revenue was only 22.4%. Also pleased to see the dividend increased 17%, they now yield 6%.

I need to see the gap closing between reported earnings and adjusted earnings, the four adjusted figures I think that should either disappear or significantly reduce now are, restructuring costs, Impairment of goodwill/intangibles, Amortisation of intangibles and Start Up costs. I would like to see at least £3,765m returned to the basic results.

The board sound much more upbeat now, in the 2011 full year statement they said "At this early stage of the year the Board is optimistic that current expectations for 2011 can be met". In 2012 they used the same sentence to sum up expectations, but yesterday the said "Board is confident that current year expectations will be met"

As long as the stronger growth from Q4, which has continued into 2013 continues through out the year, then I would hope this may be a good time buy back in. They were on a PER for 2013 of 6.65, so I will await new estimates with interest.

ic2...

interceptor2
14/3/2013
10:19
Very wierd coincidence ic2! :0))
cfro
14/3/2013
09:12
That's a coincidence I was thinking along the same lines :o)

I did take a small position yesterday in case they have turned the corner now.

ic2...

interceptor2
14/3/2013
09:08
No comments on yesterdays results means these are somewhat neglected. They might be turning a corner now tho with a bit of luck.
cfro
Chat Pages: Latest  32  31  30  29  28  27  26  25  24  23  22  21  Older

Your Recent History

Delayed Upgrade Clock